[Controlled study of the liver-protective effect of cycloxilic acid in a form of iatrogenic liver disease].
D000328:Adult; D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D004917:Erythromycin / Q000031:analogs & derivatives*; D004918:Erythromycin Estolate / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000187:drug effects*; D008875:Middle Aged; D013203:Staphylococcal Infections / Q000188:drug therapy*
D003509:Cyclohexanecarboxylic Acids; D004917:Erythromycin; D004918:Erythromycin Estolate
Studio controllato dell'effetto antiepatotossico dell'acido ciclossilico in una forma di epatopatia iatrogena.